Results 301 to 310 of about 92,434 (342)

Update on outcome assessment in myositis

open access: yesNature Reviews Rheumatology, 2018
Lisa G Rider   +2 more
exaly   +2 more sources

Pathological autoantibody internalisation in myositis

Annals of the Rheumatic Diseases
Objectives Autoantibodies targeting intracellular proteins are common in various autoimmune diseases. In the context of myositis, the pathologic significance of these autoantibodies has been questioned due to the assumption that autoantibodies cannot ...
Iago Pinal-Fernández   +30 more
semanticscholar   +1 more source

Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors

Arthritis & Rheumatology, 2020
To estimate the incidence of immune checkpoint inhibitor–related myositis (ICI‐myositis) in cancer patients receiving ICIs, and to report associated clinical manifestations, patterns of care, and outcomes.
J. Aldrich   +8 more
semanticscholar   +1 more source

Myositis and malignancy

Current Opinion in Rheumatology, 1984
Dermatomyositis appears to be associated with a greater frequency of malignancy than expected in the general population. For polymyositis, there does not appear to be a greatly increased risk of malignancy. Ovarian cancer may be overrepresented in women with dermatomyositis and difficult to detect.
openaire   +5 more sources

Ocular Myositis

Current Allergy and Asthma Reports, 2012
Ocular myositis frequently manifests with orbital pain and diplopia. The diagnosis of ocular myositis falls within the overall classification of idiopathic orbital inflammatory diseases, defined as non-infective non-specific orbital inflammation without identifiable local or systemic causes.
Avinash Gurbaxani   +3 more
openaire   +3 more sources

Therapy for myositis

Current Opinion in Rheumatology, 1991
The mainstay of therapy for polymyositis-dermatomyositis continues to be corticosteroids either alone or in combination with other immunosuppressive agents. Intravenous cyclophosphamide may be beneficial in some patients, and success with cyclosporine has been reported in children with dermatomyositis.
openaire   +3 more sources

Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis

Rheumatology International, 2016
We aimed to study the prevalence and clinical associations of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) in a large cohort of Indian patients with idiopathic inflammatory myositis (IIM). Clinical details and serum samples were collected from patients with IIM (satisfying Bohan and Peter Criteria, 1975) and CTD-
Sanjay Dwivedi   +2 more
openaire   +3 more sources

Myositis in children

Current Opinion in Rheumatology, 2001
Idiopathic inflammatory myositis in children includes multiple disease entities, but is primarily made up of juvenile dermatomyositis and, to a lesser degree, juvenile polymyositis. Much new information has been published in the last few years about these diseases, including the epidemiology, pathogenesis, clinical diagnosis, and outcomes and treatment.
openaire   +3 more sources

Inflammatory myositis in systemic lupus erythematosus

Lupus, 2020
Background The coexistence of inflammatory myositis in systemic lupus erythematosus (SLE) has not been extensively studied. In this study, we describe the incidence, distinct types of inflammatory myositis, and risk factors for this finding in a cohort ...
N. Bitencourt   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy